Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study

[1] Bijker N(2006)Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 3381-3387

[2] Meijnen P(2020)Association of a diagnosis of ductal carcinoma in situ with death from breast cancer JAMA Netw Open 3 e2017124-958

[3] Peterse JL(2018)Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ Ann Surg 267 952-249

[4] Giannakeas V(2008)Development of new cancers in patients with DCIS: the M.D. Anderson experience Ann Surg Oncol 15 244-896

[5] Sopik V(2015)Breast cancer mortality after a diagnosis of ductal carcinoma in situ JAMA Oncol 1 888-427

[6] Narod SA(2012)Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast Breast J 18 420-17

[7] Elshof LE(2008)Ductal carcinoma in situ: through a glass, darkly Ann Surg Oncol 15 16-390

[8] Schmidt MK(2005)Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging Breast J 11 382-30

[9] Rutgers EJT(2001)MR imaging of the breast for the detection, diagnosis, and staging of breast cancer Radiology 220 13-3258

[10] van Leeuwen FE(2008)Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer J Clin Oncol 26 3248-5649

[1] Bijker N(2006)Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 3381-3387

[2] Meijnen P(2020)Association of a diagnosis of ductal carcinoma in situ with death from breast cancer JAMA Netw Open 3 e2017124-958

[3] Peterse JL(2018)Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ Ann Surg 267 952-249

[4] Giannakeas V(2008)Development of new cancers in patients with DCIS: the M.D. Anderson experience Ann Surg Oncol 15 244-896

[5] Sopik V(2015)Breast cancer mortality after a diagnosis of ductal carcinoma in situ JAMA Oncol 1 888-427

[6] Narod SA(2012)Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast Breast J 18 420-17

[7] Elshof LE(2008)Ductal carcinoma in situ: through a glass, darkly Ann Surg Oncol 15 16-390

[8] Schmidt MK(2005)Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging Breast J 11 382-30

[9] Rutgers EJT(2001)MR imaging of the breast for the detection, diagnosis, and staging of breast cancer Radiology 220 13-3258

[10] van Leeuwen FE(2008)Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer J Clin Oncol 26 3248-5649